📰 Iagnostics News
Page 73 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
August 9, 2022
In partnership with BGI Genomics from China, Serbia's first genome sequencing center, opened in December 2021, is monitoring potential virus mutations to facilitate more effective COVID-19 control and accelerating access to genomics to enhance health outcomes.
August 9, 2022
SILICON VALLEY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Predicine, Inc., a global molecular insights company, has launched its CE-marked PredicineCARE™...
August 9, 2022
Cincinnati, Ohio, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Gravity Diagnostics, a clinical laboratory company in Northern Kentucky, has partnered with the...
August 9, 2022
SelectScience is a scientific publication for product news, application notes, events, videos and laboratory product reviews.
August 8, 2022
Dublin, Aug. 08, 2022 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostics - Global Market Trajectory & Analytics" report has been added to...
August 5, 2022
After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell...
August 4, 2022
The Best You debuts the first digital skincare experience for medical aesthetic clinics in Canada, guiding customers on their skincare journey of healthy self-image enhancement. Helsinki, Finland and
August 4, 2022
Imperial researchers have built a new easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly.
August 3, 2022
By the year 2060, projected rates of cardiovascular risk factors and disease will increase significantly in the United States, according to a study published today in the Journal of the American College of Cardiology. Substantial increases in cardiovascular trends may contribute to a rising burden on the U.S. health care system and highlight the need for equitable access to prevention education and treatments now to prevent future disease.
August 3, 2022
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding